Moon and Balasubramanian 2001
In contrast, Garkell et al. (2004) contend that it is the perceived absence of benefits and not the assessment of risks that accounts for the low index of acceptance of GM foods by the European public. The authors reviewed the results of an earlier study where they used the Eurobarometer survey on biotechnology (EB52.1) to ask 1000 respondents in each of 17 European countries their opinions on whether each of 7 biotechnologies was (1) useful (an index of benefit), (2) risky (an index of risk), and (3) morally acceptable (an index of support) (Garkell et al. 2000). GM food ...